Cite Filings / STLN / 0001104659-21-147819
Feed Companies Filings Check
Sign in
Cite Filings

Pages

  • Feed
  • Companies
  • Filings
  • Check a claim

Account

  • Sign in
  • Create an account
Support (opens in new tab)
8-K

Current Report

Starling Oncology, Inc. · Filed 2021-12-09 · Acc 0001104659-21-147819

Restatement

  • Item 4.02 Non-reliance on previously issued financial statements

From the SEC's structured data for this filing

Documents 1

  • 8-K Current Report , tm2134944d1_8k.htm

Around this filing

  • 2022-03-07 8-K Executive or director change · Regulation FD disclosure
  • 2021-12-14 10-Q/A 10-Q/A
  • 2021-12-14 10-K/A 10-K/A
  • 2021-12-10 SC 13G Amended Statement of Ownership
  • 2021-12-09 8-K Restatement
  • 2021-11-18 8-K Material agreement · Acquisition or sale completed · Unregistered share sale · Shareholder rights changed · Auditor change · Change in control · Executive or director change · Bylaws or fiscal year change · Code of ethics change · Shell status change · Other events

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)
  • SEC Structured Data (opens in new tab)
Loading tm2134944d1_8k.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…